These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16047323)

  • 21. Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties.
    Guy JA; Shea M; Peter CP; Morrissey R; Hayes WC
    Calcif Tissue Int; 1993 Oct; 53(4):283-8. PubMed ID: 8275358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alendronate on fracture healing and bone remodeling in dogs.
    Peter CP; Cook WO; Nunamaker DM; Provost MT; Seedor JG; Rodan GA
    J Orthop Res; 1996 Jan; 14(1):74-9. PubMed ID: 8618170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model.
    Shaul JL; Hill RS; Bouxsein ML; Burr DB; Tilton AK; Howe JG
    Bone; 2022 Jan; 154():116246. PubMed ID: 34744020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.
    Tang SY; Allen MR; Phipps R; Burr DB; Vashishth D
    Osteoporos Int; 2009 Jun; 20(6):887-94. PubMed ID: 18850239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent Parathyroid Hormone After Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats.
    Altman-Singles AR; Jeong Y; Tseng WJ; de Bakker CM; Zhao H; Lott C; Robberts J; Qin L; Han L; Kim DG; Liu XS
    J Bone Miner Res; 2017 Aug; 32(8):1703-1715. PubMed ID: 28467646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the effect of pulsed wave low-level laser therapy on the biomechanical properties of the vertebral body in two experimental osteoporosis rat models.
    Bayat M; Fridoni M; Nejati H; Mostafavinia A; Salimi M; Ghatrehsamani M; Abdollahifar MA; Najar A; Bayat S; Rezaei F
    Lasers Med Sci; 2016 Feb; 31(2):305-14. PubMed ID: 26719056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
    Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
    Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs.
    Burr DB; Liu Z; Allen MR
    Bone; 2015 Feb; 71():58-62. PubMed ID: 25445446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alendronate: a bisphosphonate for treatment of osteoporosis.
    Kirk JK; Spangler JG
    Am Fam Physician; 1996 Nov; 54(6):2053-60. PubMed ID: 8900364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risedronate: a new oral bisphosphonate.
    Umland EM; Boyce EG
    Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of osteoporosis medications on bone quality.
    Benhamou CL
    Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
    Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H
    J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
    Yano T; Yamada M; Inoue D
    Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term alendronate treatment on bone mineralisation, resorption parameters and biomechanics of single human vertebral trabeculae.
    Krause M; Soltau M; Zimmermann EA; Hahn M; Kornet J; Hapfelmeier A; Breer S; Morlock M; Wulff B; Püschel K; Glueer CC; Amling M; Busse B
    Eur Cell Mater; 2014 Sep; 28():152-63; discussion 163-5. PubMed ID: 25241965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.
    Ma S; Goh EL; Jin A; Bhattacharya R; Boughton OR; Patel B; Karunaratne A; Vo NT; Atwood R; Cobb JP; Hansen U; Abel RL
    Sci Rep; 2017 Mar; 7():43399. PubMed ID: 28262693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of alendronate on particle-induced osteolysis in a rat model.
    Millett PJ; Allen MJ; Bostrom MP
    J Bone Joint Surg Am; 2002 Feb; 84(2):236-49. PubMed ID: 11861730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates.
    Ding M; Day JS; Burr DB; Mashiba T; Hirano T; Weinans H; Sumner DR; Hvid I
    Calcif Tissue Int; 2003 Jun; 72(6):737-44. PubMed ID: 14563003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.